Comvita Limited

CVT

NZCVTE0001S7

Food Processing

End-of-day quote New Zealand S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
2.07 ^NZD	-0.96%		+0.98%	-10.00%

Feb. 23	Comvita Receives Non-Binding Takeover Offer; Shares Rally 11%	MT
Feb. 22	An unknown buyer has agreed to acquire all shares of Comvita Limited.	CI

Comvita Limited acquired an additional 12% stake in Apiter Laboratories for $2 million.

October 19, 2023

Comvita Limited (NZSE:CVT) acquired an additional 12% stake in Apiter Laboratories for $2 million on October 20, 2023. Comvita Limited will now hold 32% Apiter S.A.

Comvita Limited (NZSE:CVT) completed the acquisition of an additional 12% stake in Apiter Laboratories on October 20, 2023

Latest news about Comvita Limited

Comvita Receives Non-Binding Takeover Offer; Shares Rally 11%	Feb. 22	MT
An unknown buyer has agreed to acquire all shares of Comvita Limited.	Feb. 21	CI
Comvita Posts 8% Decline in H1 FY24 Revenue, Swings to Net Loss	Feb. 20	MT
Transcript : Comvita Limited, H1 2024 Earnings Call, Feb 21, 2024	Feb. 20
Comvita Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 20	CI
New Zealand Shares Rebound As Investors Ponder Unlikely March US Rate Cut; Air New Zealand's Passenger Count Rises	Feb. 01	MT
Comvita's Fiscal H1 Revenue Falls 8%; Downgrades Fiscal Year 2024 Guidance; Shares Slump 11%	Jan. 31	MT
Comvita Limited acquired an additional 12% stake in Apiter Laboratories for $2 million.	23-10-19	CI
Comvita Limited Approves the Appointment of Michael Sang as Director	23-10-03	CI
Transcript : Comvita Limited - Shareholder/Analyst Call	23-10-03
Comvita Limited Announces Final Fully Imputed Dividend for the Full Year 2023	23-08-21	CI
Transcript : Comvita Limited, 2023 Earnings Call, Aug 22, 2023	23-08-21
Comvita Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-21	CI
Comvita Limited acquired Swift Health Food Pte Ltd.	23-07-02	CI
Comvita Limited Announces Changes to Board of Directors, Effective from September 30, 2023	23-03-08	CI
Comvita Launches New Manuka Honey for Kids & Debuts Convenient Squeeze Bottles At Natural Products Expo West	23-03-07	CI
Comvita Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
Transcript : Comvita Limited, H1 2023 Earnings Call, Feb 23, 2023	23-02-22
Transcript : Comvita Limited - Shareholder/Analyst Call	22-09-28
Comvita Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-25	CI
Comvita Limited Provides Earnings Guidance for the Year 2023	22-08-25	CI
Comvita Limited Announces Final Dividend for the Year Ended June 30, 2022, Payable on 7 October 2022	22-08-25	CI
NZ shares extend losses as inflation woes weigh; Australian markets shut	22-06-13	RE
Comvita to Seek M&A	22-02-23	CI
Transcript : Comvita Limited, H1 2022 Earnings Call, Feb 24, 2022	22-02-23

Chart Comvita Limited

Duration

Period

More charts

Company Profile

Comvita Limited is engaged in manufacturing and marketing nature health products, apiary ownership and native forest management. It is also involved in research, manufacturing and distributing manuka honey, bee products and olive leaf products. It segments include Greater China, Australia, and New Zealand (ANZ), Rest of Asia, North America, and Europe, Middle East, and Africa (EMEA). Its product category includes Kids Health, Manuka Honey, Medihoney, Olive Leaf Extract, Oral Care, Propolis, Bundle Packs, Elixirs and Lozenges, and Gourmet Honey. Its products under Kids Health include Children's Manuka Honey Elixir, Kids Honey, and Kids Day-time Soother Bundle, among others. Its products under Manuka Honey include Manuka Lovers Luxury Pack, Manuka Blend Honey, and Manuka Blend Honey MGO, among others. Medihoney Wound Gel is its Medihoney product. Its Olive Leaf Extract products include Manuka Honey Lozenges Olive Leaf Extract and Manuka Honey Lozenges Olive Leaf Extract 12 Lozenges.

Sector

Food Processing

More about the company

Income Statement Evolution

More financial data

Ratings for Comvita Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2.07 NZD

Average target price

2.1 NZD

Spread / Average Target

+1.45%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
COMVITA LIMITED	-10.00%	86.2M
ZHEJIANG NHU COMPANY LTD.	+8.20%	7.78B
BELLRING BRANDS, INC.	+0.34%	7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.20%	6.52B
BYHEALTH CO., LTD	-8.10%	3.67B
THE SIMPLY GOOD FOODS COMPANY	-13.13%	3.44B
XIAMEN KINGDOMWAY GROUP COMPANY	-14.57%	1.17B
SIRIO PHARMA CO., LTD.	+8.34%	934M
HERBALIFE LTD.	-42.27%	879M
USANA HEALTH SCIENCES, INC.	-18.90%	836M

Special Foods & Wellbeing Products

Comvita Limited

Equities

CVT

NZCVTE0001S7

Food Processing

Comvita Limited acquired an additional 12% stake in Apiter Laboratories for $2 million.

Latest news about Comvita Limited

Chart Comvita Limited

Company Profile

Income Statement Evolution

Ratings for Comvita Limited

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Special Foods & Wellbeing Products